stock today
move piec despit solid ep guidanc rais half ep increas
relat pharmedium exit half relat better core distribut
oper result abc stock today believ may coupl
factor first investor like hope balanc sheet benefit
pharmedium decis shutdown instead sale investor
get ep boost asid follow-up discuss compani
manag said would receiv larg mln cash tax benefit cash
flow either scenario uniqu relat shutdown
manag also note anoth pharmedium facil new jersey
would exacerb oper loss move forward beyond mln
quarterli run rate shut busi altogeth
second ep growth expect low end annual rang
despit new benefit pharmedium exit like least mln tailwind
mathemat suggest abc core ebit flat
year ago period saw sg benefit effect neutral loss
pharmedium period see figur expect see
expens grow lap benefit trend similar rest well
also shown figur
rais ep estim told abc driver ep growth includ specialti
distribut physician servic ion solut gpo back today
result rais ep reflect pharmedium loss
remov out-performance core busi rel expect also
rais ep expect slightli higher ebit growth
pharma distribut busi move forward rel origin expect
maintain pt base price-to-earnings ep
quarterli annual ep usd
consensu number bloomberg receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
idc link barclay live interact chart
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
equal weight rebound gener
deflat eas compani specif issu abat
specialti continu growth driver howev
still remain larg opioid settlement
yet determin weigh stock
upsid case see better growth specialti
improv underli oper lead
downsid case see larger expect opioid
settlement higher expect litig
expens associ
 annual oper profit mil abcabcabcabcabcoper profit ebit ebitpharma distribut strateg global pharmedium approxim one-tim pharma growthmid high singl digit growthmid high singl digit growthoper expens growthmid singl digit growthmid singl digit growthdistribut servic op profit growthlow mid singl digit growthmid-singl digit rangeoth op profit growthhigh singl digit growthhigh singl digit growthoper profit growthlow mid singl digit growthmid-singl digit growthnet erest expenseadj effect tax inflationsimilar deflationsimilar mlnadjust mlnnotesleas account headwindleas account headwindto pharma ebit off-set expto pharma ebit off-set ep lower part full year ep low end growth barclay corp
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
unless otherwis indic price sourc bloomberg reflect close price relev trade market may
last avail price time public
barclay bank plc and/or affili lead manag co-lead manag publicli disclos offer secur issuer
 employe non-execut director barclay plc director issuer
cd barclay bank plc and/or affili market-mak debt secur issu issuer
ce barclay bank plc and/or affili market-mak equiti secur issu issuer
barclay bank plc and/or affili receiv compens invest bank servic issuer past month
 barclay bank plc and/or affili expect receiv intend seek compens invest bank servic issuer
within next month
fa barclay bank plc and/or affili benefici own class equiti secur issuer calcul accord
us regul
fb barclay bank plc and/or affili benefici own long posit class equiti secur issuer
calcul accord eu regul
fc barclay bank plc and/or affili benefici own short posit class equiti secur issuer
calcul accord eu regul
fd barclay bank plc and/or affili benefici own class equiti secur issuer calcul accord
south korean regul
gd one analyst fundament credit coverag team member household financi interest debt
equiti secur issuer
ge one analyst fundament equiti coverag team member household financi interest debt
equiti secur issuer
 issuer benefici own class common equiti secur barclay plc
barclay bank plc and/or affili parti agreement issuer provis financi servic barclay bank plc and/or
affili
 barclay bank plc and/or affili liquid provid and/or trade regularli secur issuer and/or relat
